530057 VIVANZA

Vivanza Biosciences Share PriceVivanza Biosciences

₹8.55
-0.44 (-4.89%)
As on 09 December, 2023 | 08:16 BSE: 530057 NSE: VIVANZAISIN: INE984E01035

Vivanza Biosciences Performance

Day Range

  • Low
  • High
₹ 8.55

52 Week Range

  • Low
  • High
₹ 8.55
  • Open Price
  • Previous Close
  • Volume

Start SIP in Vivanza Biosciences

Start SIP

Vivanza Biosciences Share Price

  • Over 1 Month -28.15%
  • Over 3 Month -35.96%
  • Over 6 Month -31.65%
  • Over 1 Year -39.49%

Vivanza Biosciences Key Statistics

Vivanza Biosciences Investment Rating

  • Master Rating:
  • Vivanza Biosciences has an operating revenue of Rs. 30.95 Cr. on a trailing 12-month basis. An annual revenue growth of 63% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 14% is good. The company has a reasonable debt to equity of 35%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 97 which is a GREAT score indicating consistency in earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 74 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Vivanza Biosciences Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 4565126
Operating Expenses Qtr Cr 4464126
Operating Profit Qtr Cr 0001000
Depreciation Qtr Cr 0000000
Interest Qtr Cr 0000000
Tax Qtr Cr 0000000
Net Profit Qtr Cr 0000000
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 1510
Operating Expenses Annual Cr 139
Operating Profit Annual in Cr 10
Depreciation Cr 00
Interest Annual Cr 00
Tax Annual Cr 00
Net Profit Annual Cr 10
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 0-1
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr 01
Net Cash Flow Annual Cr 00
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 44
Fixed Assets Annual Cr 00
Total Non Current Assets Annual Cr 33
Total Current Assets Annual Cr 189
Total Assets Annual Cr 2011
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 110
ROE Annual % 1312
ROCE Annual % 2523
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 810
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 8986126
Operating Expenses Qtr Cr 7985126
Operating Profit Qtr Cr 0101000
Depreciation Qtr Cr 0000000
Interest Qtr Cr 0000000
Tax Qtr Cr 0000000
Net Profit Qtr Cr 0000000
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 1811
Operating Expenses Annual Cr 1710
Operating Profit Annual in Cr 10
Depreciation Cr 00
Interest Annual Cr 00
Tax Annual Cr 00
Net Profit Annual Cr 10
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr -1
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr 1
Net Cash Flow Annual Cr 0
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 43
Fixed Assets Annual Cr 11
Total Non Current Assets Annual Cr 33
Total Current Assets Annual Cr 2010
Total Assets Annual Cr 2213
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 19
ROE Annual % 1510
ROCE Annual % 2112
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 67

Vivanza Biosciences Technicals

EMA & SMA

Current Price
₹8.55
-0.44 (-4.89%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹9.06
  • 50 Day
  • ₹10.08
  • 100 Day
  • ₹11.06
  • 200 Day
  • ₹11.97
  • 20 Day
  • ₹8.67
  • 50 Day
  • ₹10.34
  • 100 Day
  • ₹11.48
  • 200 Day
  • ₹12.72

Vivanza Biosciences Resistance and Support

PIVOT
₹8.87
Resistance
First Resistance 9.18
Second Resistance 9.68
Third Resistance 10.00
RSI 41.40
MFI 50.80
MACD Single Line -0.70
MACD -0.53
Support
First Resistance 8.36
Second Resistance 8.04
Third Resistance 7.54

Vivanza Biosciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 11,323 1,132,300 100
Week 26,580 2,658,040 100
1 Month 52,084 4,947,971 95
6 Month 21,384 2,084,262 97.47

Vivanza Biosciences Result Highlights

Vivanza Biosciences Synopsis

BSE-Medical-Diversified

Vivanza Biosciences is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 14.21 Cr. and Equity Capital is Rs. 4.00 Cr. for the Year ended 31/03/2023. Vivanza Biosciences Ltd. is a Public Limited Listed company incorporated on 06/03/1982 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1982PLC005057 and registration number is 005057.
Market Cap 34
Sales 20
Shares in Float 0.21
No of funds 2
Yield
Book Value 7.77
U/D Vol ratio
LTDebt / Equity
Alpha 0.85
Beta -0.62

Vivanza Biosciences

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 47.29%47.8%47.8%47.8%
Financial Institutions/ Banks
Individual Investors 6.23%5.66%5.65%5.67%
Others 46.48%46.54%46.55%46.53%

Vivanza Biosciences Management

Name Designation
Mr. Mehta J A Managing Director
Ms. A S Vyas Independent Woman Director
Mr. Parikh H A Director
Mr. Shah S D Independent Director

Vivanza Biosciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Vivanza Biosciences Corporate Action

Date Purpose Remarks
2023-10-26 Quarterly Results
2023-08-10 Quarterly Results
2023-06-30 A.G.M. Inter alia, to consider and approve the Directors Report and Secretarial Audit Report along with annexure for the Financial Year 2022-23. split from Rs. 10/- to Re. 1/-.
2023-04-25 Audited Results
2023-03-04 Stock Split
Date Purpose Remarks
2023-03-24 Split Rs.0.00 split from Rs. 10/- to Re. 1/-.

Vivanza Biosciences FAQs

What is Share Price of Vivanza Biosciences ?

Vivanza Biosciences share price is ₹8 As on 09 December, 2023 | 08:02

What is the Market Cap of Vivanza Biosciences ?

The Market Cap of Vivanza Biosciences is ₹34.2 Cr As on 09 December, 2023 | 08:02

What is the P/E ratio of Vivanza Biosciences ?

The P/E ratio of Vivanza Biosciences is 30.8 As on 09 December, 2023 | 08:02

What is the PB ratio of Vivanza Biosciences ?

The PB ratio of Vivanza Biosciences is 8.4 As on 09 December, 2023 | 08:02

Q2FY23